Anti-Viral Agents, Volume 67

1st Edition

Editors: Erik De Clercq
Hardcover ISBN: 9780124058804
eBook ISBN: 9780124055377
Imprint: Academic Press
Published Date: 12th August 2013
Page Count: 384
195.00 + applicable tax
155.00 + applicable tax
256.00 + applicable tax
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Table of Contents

Preface

References

Contributors

Chapter One. Antiviral Agents for Herpes Simplex Virus

Abbreviations

1 Introduction

2 Historical Overview: Therapies for HSV Infections

3 Clinical Experience with ACV, VACV, and FCV Through Two Decades

4 Antiviral Drug Resistance

5 Novel Approaches to HSV Chemotherapy

6 Prospects for Novel Antiviral Compounds and Vaccines

7 Conclusion

Conflict of Interest

References

Further Reading

Chapter Two. Nucleotide Prodrugs for the Treatment of HCV Infection

Abbreviations

1 Introduction

2 Nucleoside Inhibitors

3 Nucleotide Prodrugs

4 Conclusion

Conflict of Interest

References

Chapter Three. HIV Integrase Inhibitors: 20-Year Landmark and Challenges

Abbreviations

1 Introduction

2 Requirement of IN for HIV Replication

3 IN Structure

4 The INSTIs

5 Challenges

6 Conclusion

Conflict of Interest

References

Chapter Four. Advances in the Treatment of Varicella-Zoster Virus Infections

Abbreviations

1 Introduction

2 Vaccination Strategies and Postexposure Prophylaxis

3 Existing Antiviral Treatments

4 Medical Need for New Anti-VZV Agents

5 Development of Novel Anti-VZV Agents

6 Candidate Anti-VZV Drugs

7 Perspectives

8 Conclusion

Conflict of Interest

Acknowledgments

References

Chapter Five. Hepatitis C Virus: Standard-of-Care Treatment

Abbreviations

1 Introduction

2 Curing HCV Infection

3 Interferons

4 Ribavirin

5 Direct HCV Inhibitors (DAAs and HTAs)

6 Interferon-Based Strategies in 2013

7 Interferon-Free Regimens in 2014 and Onward

8 Conclusion

Conflict of Interest

References

Chapter Six. Influen


Description

This new volume of Advances in Pharmacology explores the current state of antiviral agents. Chapters cover such topics as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike.

Key Features

  • Explores the current state of anti-viral agents
  • Chapters cover a variety of topics such as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV
  • With the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike

Readership

Pharmacologists, immunologists, and biochemists


Details

No. of pages:
384
Language:
English
Copyright:
© Academic Press 2013
Published:
Imprint:
Academic Press
eBook ISBN:
9780124055377
Hardcover ISBN:
9780124058804

About the Editors

Erik De Clercq Editor